SenoRx was co-founded by breast care
physicians who recognized an unmet need to improve patient outcomes
for each of the steps associated with the diagnosis and treatment
of breast cancer. Years of experience working with breast cancer
patients demonstrated that traditional technologies sometimes resulted
in discordant findings, false negatives or even positive margins,
all of which required patients to undergo additional costly procedures.
For each of the steps: Biopsy, Marking, Fixation, Detection and
Excision, the physicians sought to develop technologies that would
provide more accurate and consistent clinical results. In a relatively
short period of time, SenoRx has introduced an array of minimally
invasive products that have been clinically proven to enhance patient
outcomes. These are some of the SenoRx technological advancements:
|
